two major drug companies posted strong third-quarter_earnings , in line with profits already reported by industry leaders and analysts_' expectations . but pfizer inc. , based in new_york , reported flat earnings . schering-plough corp. , based in madison , n.j. , reported a 21_% rise in earnings as american_home products corp. of new_york posted an 11_% increase in net . american_home products american_home products said_0 sales and earnings for the third_quarter and nine_months were at record levels . sales for the third_quarter increased 6.5_% to $ 1.51 billion from $_1.42 billion . sales of health-care_products increased 6_% in the third_quarter , based in part on strong_sales of prescription_drugs such_as premarin , an estrogen-replacement drug , and sales of the company 's infant formula . american_home products said_0 net_income benefited_from a `` lower effective_tax rate , '' reflecting a reduction of foreign tax_rates , and additional operations in puerto_rico . net also was aided_by a gain on the sale of the company 's equity interests in south_africa effective sept. 1 . in new_york stock_exchange composite_trading yesterday , american_home products closed_at $ 102.25 a_share , down 75_cents . pfizer pfizer said_0 third-quarter sales_increased 4_% to $ 1.44 billion from $ 1.38 billion . the company said_0 net_income was flat because of investment in research and development and costs related to launches of several products . the company said_0 the dollar 's continued strengthening reduced world-wide_sales growth by three percentage_points . pfizer posted its largest gains in healthcare sales , up 3_% , and consumer_products , up 23_% . sales by the specialty_chemicals and materials science segments were_flat , and sales by the agriculture segment declined 5_% . in the health-care segment , pharmaceutical sales_increased 4_% and sales of hospital products increased 1 % . during the quarter , pfizer received federal approval of procardia xl , a calcium channel blocker approved for both angina and hypertension , and monorail piccolino , used to open obstructed coronary arteries . in new_york stock_exchange composite_trading yesterday , pfizer closed_at $ 67.75 a_share , up 75_cents . schering-plough schering-plough said_0 sales gained 2.7 % to $ 743.7 million from $ 724.4 million . in the period , the company completed the sale of its european cosmetics businesses , sold a majority interest in its brazilian affiliate , and announced the reorganization of its over-the-counter drug businesses into a new unit , schering-plough health_care products . these actions did_n't affect results because the gain on the sale of the european cosmetics businesses was offset_by provisions relating to the brazil divestiture and drug restructuring . u.s. pharmaceutical sales_rose 15_% , led_by allergy , asthma and cold products ; dermatological products ; anti-infectives and anti-cancer products ; and cardiovascular products . world-wide consumer product sales declined 12_% , primarily_because of the european cosmetics sale . significantly_lower sales of ` stay trim ' diet aids also were a factor in the drop . the maybelline beauty product_line had higher sales following a sluggish first_half . in big_board composite_trading , schering-plough shares fell 75_cents to close_at $ 74.125 .